background image

Paid Clinical Trials San Jose

Discover 2,096 paid clinical trials in San Jose, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of EP0031 in Patients With Advanced RET-altered Malignancies

Recruiting
PHASE1
PHASE2

Sponsor:

Ellipses Pharma

Location:

Stanford CA, Los Angeles CA, Portland OR, Seattle WAshow 12 more

Code:

NCT05443126

Conditions

Advanced Solid Tumor

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

EP0031

A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis

Recruiting
PHASE2

Sponsor:

Pfizer

Location:

San Francisco CA, Garden Grove CA, Orange CA, San Bernardino CAshow 14 more

Code:

NCT05287126

Conditions

Ulcerative Colitis

Eligibility Criteria

Sex: All

Age: 12 - 17

Healthy Volunteers: Not accepted

Interventions

Etrasimod

A Trial Comparing Unrelated Donor BMT with IST for Pediatric and Young Adult Patients with Severe Aplastic Anemia (TransIT, BMT CTN 2202)

Recruiting
PHASE3

Sponsor:

Boston Children's Hospital

Location:

Palo Alto CA, Oakland CA, San Francisco CA, Los Angeles CAshow 43 more

Code:

NCT05600426

Conditions

Severe Aplastic Anemia

Eligibility Criteria

Sex: All

Age: 0 - 25

Healthy Volunteers: Not accepted

Interventions

cyclosporine

Matched Unrelated Donor Hematopoetic Stem Cell Transplant

horse anti-thymocyte globulin (ATG)

rabbit anti-thymocyte globulin (ATG)

Methotrexate

Real-World Study of ABBV-951 Subcutaneous Infusion to Assess Change in Disease Activity in Adult Participants With Parkinson's Disease

Recruiting

Sponsor:

AbbVie

Location:

Palo Alto CA, Sun City AZ, Spokane WA, Calgaryshow 8 more

Code:

NCT06107426

Conditions

Parkinson's Disease (PD)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Disease (MOG-AD)

Recruiting
PHASE3

Sponsor:

UCB Biopharma SRL

Location:

Palo Alto CA, Salt Lake City UT, Scottsdale AZ, Aurora COshow 10 more

Code:

NCT05063162

Conditions

Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOG-AD)

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Rozanolixizumab

Placebo

Low-Dose Naltrexone for the Treatment of Complex Regional Pain Syndrome

Recruiting

Sponsor:

Stanford University

Location:

Palo Alto CA

Code:

NCT02502162

Conditions

Complex Regional Pain Syndrome

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

LDN

Placebo

ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)

Recruiting
PHASE3

Sponsor:

Chimerix

Location:

Stanford CA, San Francisco CA, Santa Monica CA, Los Angeles CAshow 53 more

Code:

NCT05580562

Conditions

H3 K27M

Glioma

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Dordaviprone (ONC201)

Dordaviprone (ONC201) + Placebo

Placebo

Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma

Recruiting
PHASE1

Sponsor:

C. Babis Andreadis

Location:

San Francisco CA

Code:

NCT04545762

Conditions

Refractory Non-Hodgkin Lymphoma

Burkitt Lymphoma

Mantle Cell Lymphoma

Follicular Lymphoma

Lymphoplasmacytic Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Fludarabine

Cyclophosphamide

anti-CD19 CAR-T cells

DALY II USA/ MB-CART2019.1 for DLBCL

Recruiting
PHASE2

Sponsor:

Miltenyi Biomedicine GmbH

Location:

Stanford CA, La Jolla CA, Portland OR, Phoenix AZshow 18 more

Code:

NCT04792489

Conditions

Refractory Diffuse Large B Cell Lymphoma (DLBCL)

Relapsed Diffuse Large B Cell Lymphoma

High Grade B-cell Lymphoma (HGBCL)

Primary Mediastinal B-cell Lymphoma (PMBCL)

Transformed Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

zamtocabtagene autoleucel (MB-CART2019.1)

Cyclophosphamide

Fludarabine

Bendamustine

Human Embryonic Stem Cell-Derived Cardiomyocyte Therapy for Chronic Ischemic Left Ventricular Dysfunction

Recruiting
PHASE1

Sponsor:

Joseph C. Wu

Location:

Palo Alto CA

Code:

NCT05068674

Conditions

Chronic Ischemic Left Ventricular Dysfunction

Eligibility Criteria

Sex: All

Age: 21 - 70+

Healthy Volunteers: Not accepted

Interventions

Human Embryonic Stem Cell-Derived Cardiomyocyte 50M cells

Human Embryonic Stem Cell-Derived Cardiomyocyte 150 cells

Human Embryonic Stem Cell-Derived Cardiomyocyte 300M cells